قلم مونجارو كويكبن 12.5 ملجم معبئ مسبقًا 0.6 مل

Mounjaro (tirzepatide) 12.5mg is a once-weekly prescription medicine designed to help manage blood sugar levels in adults with type 2 diabetes. As a dual GIP and GLP-1 receptor agonist, it works to improve your body's insulin production when blood sugar is high and reduces the amount of glucose your liver makes. This unique dual-action mechanism provides a robust solution for achieving and maintaining effective glycemic control.

The 12.5mg dose is a common and effective step in the treatment plan, helping patients continue their journey toward improved health outcomes, including a lower HbA1c, in combination with a healthy diet and exercise.